Antioxidant Could Lead To Safer Thalidomide, University of Cologne Study

Published: Nov 19, 2008

New Scientist -- ONE OF the big questions about the drug thalidomide was why the birth defects that affected thousands of babies in the 1950s did not show up in tests on mice. Now the compound that protected mice has been identified, and could lead to safer versions of the drug, which has been rehabilitated as a powerful anti-cancer agent.

Back to news